Notes from the Field: Increase in Coccidioidomycosis — California, 2016
Weekly / August 11, 2017 / 66(31);833–834
Gail Sondermeyer Cooksey, MPH1; Alyssa Nguyen1; Kirsten Knutson, MPH1; Farzaneh Tabnak, PhD1; Kaitlin Benedict, MPH2; Orion McCotter, MPH2; Seema Jain, MD1; Duc Vugia, MD1 (View author affiliations)View suggested citation
Views equals page views plus PDF downloads
- pdf icon [PDF]
Coccidioidomycosis, or Valley Fever, is an infectious disease caused by inhalation of Coccidioides spp. spores (1). This soil-dwelling fungus is endemic in the southwestern United States, with most (97%) U.S. cases reported from Arizona and California (1,2). Following an incubation period of 1–3 weeks, symptomatic patients most often experience self-limited, influenza-like symptoms, but coccidioidomycosis also can lead to severe pulmonary disease and to rare cases of disseminated disease, including meningitis (1). Those at increased risk for severe disease include persons of African or Filipino descent, pregnant women, adults in older age groups, and persons with weakened immune systems (1). In 2016, a large increase in coccidioidomycosis incidence was observed in California compared with previous years (3). Using data reported by health care providers and laboratories via local health departments to the California Department of Public Health as of May 9, 2017, incidence rates were calculated by estimated year of illness onset as the number of confirmed coccidioidomycosis cases per 100,000 population (3). Estimated year of illness onset was extracted from the closest date to the time when symptoms first appeared for each patient. From 1995, when coccidioidomycosis became an individually reportable disease in California, to 2009, annual incidence rates ranged from 1.9 to 8.4 per 100,000, followed by a substantial increase to 11.9 per 100,000 in 2010 and a peak of 13.8 per 100,000 in 2011 (Figure). Annual rates decreased during 2012–2014, but increased in 2016 to 13.7 per 100,000, with 5,372 reported cases, the highest annual number of cases in California recorded to date.
Coccidioidomycosis incidence rates increased disproportionately in counties considered to have endemic disease. Most cases in 2016 were in residents of the Central Valley and Central Coast regions, with 42% (2,238 cases, rate 251.7 per 100,000) reported from Kern County and 28% (1,515 cases, rate 54.5 per 100,000) from six other counties (Fresno, Kings, Madera, San Joaquin, San Luis Obispo, and Tulare) (3). From 2015 to 2016, the combined incidence from these seven counties increased 109%, from 48.9 per 100,000 (2015) to 102.3 (2016), while the rate in the remaining counties in California increased by 18% (from 3.8 to 4.5 per 100,000).
Reported 2016 incidence was highest among persons aged 40–59 years (18.8 per 100,000), compared with rates in persons aged <20 years (5.6), 20–39 years (14.9), 60–79 years (16.4) and ≥80 years (13.1). However, the sharpest increases in incidence from 2015 to 2016 occurred in persons aged <20 years (134%) and 20–39 years (90%); increases were less pronounced in persons aged 40–59 years (64%), 60–79 years (40%) and ≥80 years (35%). Rates were higher among males (17.3 per 100,000) than among females (10.0). Incidence rates by race and ethnicity were not calculated because these data were missing for approximately one third (32.7%) of reports.
Although annual coccidioidomycosis incidence rates in California and Arizona typically follow similar trends, Arizona reported a decrease in the rate from 2015 to 2016 (from 112.8 to 89.3 per 100,000) (2,4,5). In the remaining states where coccidioidomycosis was reportable in both 2015 and 2016, preliminary data show that incidence remained stable at 0.5 per 100,000 in both years.
The reasons for the increased incidence of coccidioidomycosis in California in 2016, particularly in the Central Valley and Central Coast regions, are not known, but climatic and environmental factors favorable to Coccidioides proliferation and airborne release might have contributed, including rainfall after several years of drought and soil disturbance resulting from construction (2). To decrease the risk for infection, persons living, working, or traveling in areas where Coccidioides is endemic, especially those at increased risk for severe disease, should limit exposure to outdoor dust as much as possible, including staying inside and keeping windows and doors closed during windy weather and dusty conditions (3). Previous outbreaks of coccidioidomycosis have occurred among persons working outdoors in areas where Coccidioides is endemic, including construction workers; recommendations for reducing the risk for infection on construction worksites include using personal protective respiratory equipment, dust suppression, and worker education (6,7). Health care providers should be alert for coccidioidomycosis among patients who live in or have traveled to areas where the disease is endemic, especially those who work or participate in activities where dust is generated.
California local health departments; CDC Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement.
Conflict of Interest
No conflicts of interest were reported.
Corresponding author: Gail Sondermeyer Cooksey, firstname.lastname@example.org, 510-620-3631.
1Infectious Diseases Branch, Center for Infectious Diseases, California Department of Public Health; 2Mycotic Diseases Branch, National Center for Emerging and Zoonotic Infectious Diseases, CDC.
- Galgiani JN, Ampel NM, Blair JE, et al. ; Infectious Diseases Society of America. Coccidioidomycosis. Clin Infect Dis 2005;41:1217–23. CrossRefexternal icon PubMedexternal icon
- CDC. Increase in reported coccidioidomycosis—United States, 1998–2011. MMWR Morb Mortal Wkly Rep 2013;62:217–21. PubMedexternal icon
- Tabnak F, Knutson K, Cooksey G, Nguyen A, Vugia D. Epidemiologic summary of coccidioidomycosis in California, 2016. Sacramento, CA: California Department of Public Health, Center for Infectious Diseases, Division of Communicable Disease Control; 20162017. https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/CocciEpiSummary2016.pdfpdf iconexternal icon
- Arizona Department of Health Services. Valley fever 2015 annual report. Phoenix, AZ: Arizona Department of Health Services, Office of Infectious Disease Services; 2016. http://www.azdhs.gov/documents/preparedness/epidemiology-disease-control/valley-fever/reports/valley-fever-2015.pdfpdf iconexternal icon
- Arizona Department of Health Services. Rates of reported cases of selected notifiable diseases, by category, for each county, Arizona, 2016, per 100,000 population. Phoenix, AZ: Arizona Department of Health Services, Office of Infectious Disease Services; 2017. http://www.azdhs.gov/documents/preparedness/epidemiology-disease-control/disease-data-statistics-reports/data-statistics-archive/2016/rates-by-county-2016.pdfpdf iconexternal icon
- Wilken JA, Sondermeyer G, Shusterman D, et al. Coccidioidomycosis among workers constructing solar power farms, California, USA, 2011–2014. Emerg Infect Dis 2015;21:1997–2005. CrossRefexternal icon PubMedexternal icon
- Sondermeyer Cooksey GL, Wilken JA, McNary J, et al. Dust exposure and coccidioidomycosis prevention among solar power farm construction workers in California. Am J Public Health 2017;107:1296–303. CrossRefexternal icon PubMedexternal icon
FIGURE. Number of coccidioidomycosis cases and incidence rate, by estimated year of illness onset* — California, 1995–2016
* Estimated year of illness onset was extracted from the closest date to the time when symptoms first appeared for each patient.
The figure above is a combination histogram and line graph showing the number of coccidioidomycosis cases and the incidence rate, by estimated year of illness onset, in California during 1995–2016.
Suggested citation for this article: Cooksey GS, Nguyen A, Knutson K, et al. Notes from the Field: Increase in Coccidioidomycosis — California, 2016. MMWR Morb Mortal Wkly Rep 2017;66:833–834. DOI: http://dx.doi.org/10.15585/mmwr.mm6631a4external icon.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to email@example.com.